C4 Therapeutics, Inc.CCCCNASDAQ

Revenue (LTM)

$36M

+1.0% YoY

Net Income (LTM)

$-105M

+0.3% YoY

Free Cash Flow

$-99M

Revenue CAGR (5Y)

+1.6%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	46	31↓32.1%	21↓33.3%	36↑71.4%	36↑1.0%
Gross Profit	46	31↓32.1%	13↓58.1%	36↑173.3%	28↓21.4%
Operating Income	-82	-130↓57.7%	-139↓7.3%	-120↑14.0%	-104↑12.6%
Net Income	-84	-128↓52.8%	-132↓3.4%	-105↑20.5%	-105↑0.3%
EBITDA	-80	-124↓54.9%	-122↑1.8%	-103↑15.3%	-103↑0.4%
EPS Diluted	-1.82	-2.62↓44.0%	-2.67↓1.9%	-1.52↑43.1%	-1.27↑16.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	76	30↓60.9%	127↑325.5%	55↓56.2%	75↑34.4%
Total Current Assets	326	288↓11.7%	271↓5.7%	258↓4.9%	258↑0.1%
Total Assets	507	431↓15.0%	376↓12.6%	350↓7.1%	359↑2.7%
Total Current Liabilities	51	45↓13.1%	43↓4.0%	45↑5.6%	33↓26.9%
Total Liabilities	117	142↑20.9%	130↓8.0%	134↑2.5%	102↓23.3%
Total Equity	390	289↓25.8%	246↓14.9%	216↓12.2%	257↑18.8%
Total Debt	43	87↑103.3%	71↓18.6%	66↓7.4%	60↓8.8%
Net Debt	-33	57↑272.7%	-56↓196.9%	10↑118.4%	-15↓242.5%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-87	-106↓21.8%	-107↓0.8%	-65↑39.0%	-99↓51.5%
Capital Expenditure	-1	-5↓330.4%	-2↑68.9%	-0↑89.5%	-1↓237.2%
Free Cash Flow	-88	-111↓26.3%	-109↑2.6%	-65↑39.8%	-99↓52.0%
Stock-Based Comp	22	30↑39.5%	27↓9.3%	30↑8.9%	19↓35.6%
Net Change in Cash	-105	-46↑55.8%	97↑309.2%	-71↓173.3%	19↑126.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance